Sangamo Therapeutics Inc (SGMO)

0.47 -0.53%

Sangamo Therapeutics Inc (SGMO) is currently trading at $0.47. This represents a loss of 0.53% from the previous session. With a market capitalization of $0.17B, SGMO is a key component of the Health Care sector. Investors looking to trade SGMO should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Get 15 Free Stocks on Moomoo → T&Cs Apply. Trade SGMO commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Sangamo Therapeutics Inc (SGMO) shows a bearish trend. Analysts are watching the 0.55 level closely.

Fundamentals
Mkt Cap0.17B
P/E Ratio0.0000
Volume8,106,550
Others Watching (By Market Cap)
KIDS
Orthopediatrics $16.72
+3.98% ASMB
Assembly Biosci $30.88
-0.56% ABSI
Absci Corp $2.74
+1.11% NUS
NU Skin Enterpr $8.55
+0.71% AVXL
Anavex Life Sci $4.40
+0.92%
60-Day Technical Chart
Advanced Charting

Need more indicators for SGMO? Use the world's #1 platform.

Open SGMO on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $0
Metric SGMO
-0.53% 		AGL
+26.90% 		GUTS
+4.55% 		OMI
-4.00%
Price $0.47 $0.50 $0.51 $0.48
Mkt Cap $0.17B $0.21B $0.08B $0.19B
- View → View → View →
Latest Headlines
How the Narrative Surrounding Sangamo Therapeutics Is Shifting After New Regulatory and Valuation Signals Yahoo Finance • Dec 12, 2025 One-time Fabry gene therapy lifts kidney function in early trial data Stock Titan • Feb 3, 2026 Sangamo stock plunges after pricing $25 million dilutive offering Investing.com • Feb 3, 2026 Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) Share Price Boosted 29% But Its Business Prospects Need A Lift Too simplywall.st • Feb 3, 2026 Sangamo Therapeutics (NASDAQ:SGMO) Downgraded to Strong Sell Rating by Wall Street Zen MarketBeat • Nov 16, 2025
● Gemini Agentic AI Analyst Insight for SGMO
Market Education
View All Articles →
External Research